Results 151 to 160 of about 3,241,751 (271)

Conflicts of Interest [PDF]

open access: yesJournal of the American Psychiatric Nurses Association, 2017
openaire   +2 more sources

Potential Conflicts of Interest of Editorial Board Members from Five Leading Spine Journals

open access: gold, 2015
Stein J. Janssen   +5 more
openalex   +2 more sources

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Authorship & Conflict of Interest Statement

open access: yesJournal of Dental Sciences, 2015
doaj   +1 more source

The hidden influence: Medical students' knowledge and attitude of conflict of interest-A cross-sectional study in Jeddah, Saudi Arabia. [PDF]

open access: yesPLoS One
Samargandi R   +7 more
europepmc   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

open access: yesMolecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy